Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective.Frontiers in genetics · 2020
   Article
2. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.Pharmacogenomics · 2019
   Article
3. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?Pharmaceutical research · 2017
   Review
4. The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.Biomarker research · 2016
   Article
5. Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.ISRN pharmacology · 2013
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors.

Funding

Abstract

PubMed holds no abstract for this paper.